Monday, November 11, 2013

Molecular Therapy - Table of Contents alert Volume 21 Issue 11

Molecular Therapy

Advertisement
We've always made the highest quality RNA, now we also make the best mRNA.
  • GMP Manufacturing
  • Affordable Custom Synthesis
  • Genome Editing & Manipulation Tools
  • Gene Replacement, Immunotherapy & Delivery Optimization
  • Stocked Stem Cell Reprogramming Factors
Contact us to discuss your path to pharmaceutical GMP manufacturing.

www.trilinkbiotech.com/mRNA


TABLE OF CONTENTS

Volume 21, Issue 11 (November 2013)

In this issue
Editorial
In This Issue
Research Highlights
Commentaries
Original Articles
Corrigendum

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Don't miss out! Listen to the recent Molecular Therapy podcast. 
Drs. Bambi Grilley and Helen Heslop discuss the guidelines released by the FDA that attempt to address specific issues associated with clinical trials for cell and gene therapies.
 

Editorial

Top

Finding Common Ground: A Summary of the IOM’s Review of the RAC

Mol Ther 2013 21: 1971-1972; 10.1038/mt.2013.223

Full Text

In This Issue

Top

In This Issue

Mol Ther 2013 21: 1974; 10.1038/mt.2013.224

Full Text

Research Highlights

Top

Research Highlights

Mol Ther 2013 21: 1975; 10.1038/mt.2013.225

Full Text

Commentaries

Top

Birth of a New Therapeutic Platform: 47 Years of Adeno-associated Virus Biology From Virus Discovery to Licensed Gene Therapy

Terence R Flotte

Mol Ther 2013 21: 1976-1981; 10.1038/mt.2013.226

Full Text

Enhanced Oncolytic Virotherapy Through Oxidative Stress Inhibition

Kendra L Congdon and John H Sampson

Mol Ther 2013 21: 1981-1983; 10.1038/mt.2013.227

Full Text

CAR T Cells for Acute Myeloid Leukemia: The LeY of the Land

Malcolm K Brenner

Mol Ther 2013 21: 1983-1984; 10.1038/mt.2013.234

Full Text

Original Articles

Top

Engineering of Bacteria for the Visualization of Targeted Delivery of a Cytolytic Anticancer Agent

Sheng-Nan Jiang, Seung-Hwan Park, Hee Jung Lee, Jin Hai Zheng, Hyung-Seok Kim, Hee-Seung Bom, Yeongjin Hong, Michael Szardenings, Myung Geun Shin, Sun-Chang Kim, Vasilis Ntziachristos, Hyon E Choy and Jung-Joon Min

Mol Ther 2013 21: 1985-1995; advance online publication, August 7, 2013; 10.1038/mt.2013.183

Abstract | Full Text

Inactive ERBB Receptors Cooperate With Reactive Oxygen Species To Suppress Cancer Progression

Matthew R Hart, Hsin-Yuan Su, Derrick Broka, Aarthi Goverdhan and Joyce A Schroeder

Mol Ther 2013 21: 1996-2007; advance online publication, October 1, 2013; 10.1038/mt.2013.196

Abstract | Full Text

An Infection-enhanced Oncolytic Adenovirus Secreting H. pylori Neutrophil-activating Protein with Therapeutic Effects on Neuroendocrine TumorsMTOPEN

Mohanraj Ramachandran, Di Yu, Alkwin Wanders, Magnus Essand and Fredrik Eriksson

Mol Ther 2013 21: 2008-2018; advance online publication, July 2, 2013; 10.1038/mt.2013.153

Abstract | Full Text

Measles Virus Entry Through the Signaling Lymphocyte Activation Molecule Governs Efficacy of Mantle Cell Lymphoma Radiovirotherapy

Tanner S Miest, Marie Frenzke and Roberto Cattaneo

Mol Ther 2013 21: 2019-2031; advance online publication, August 5, 2013; 10.1038/mt.2013.171

Abstract | Full Text

Antifibrotic Properties of Transarterial Oncolytic VSV Therapy for Hepatocellular Carcinoma in Rats With Thioacetamide-Induced Liver Fibrosis

Jennifer Altomonte, Sabrina Marozin, Enrico N De Toni, Antonia Rizzani, Irene Esposito, Katja Steiger, Annette Feuchtinger, Claus Hellerbrand, Roland M Schmid and Oliver Ebert

Mol Ther 2013 21: 2032-2042; advance online publication, August 13, 2013; 10.1038/mt.2013.181

Abstract | Full Text

Triptolide-Mediated Inhibition of Interferon Signaling Enhances Vesicular Stomatitis Virus-Based Oncolysis

Fethia Ben Yebdri, Julien Van Grevenynghe, Vera A Tang, Marie-Line Goulet, Jian Hui Wu, David F Stojdl, John Hiscott and Rongtuan Lin

Mol Ther 2013 21: 2043-2053; advance online publication, August 28, 2013; 10.1038/mt.2013.187

Abstract | Full Text

Vaccinia Virus-mediated Expression of Human Erythropoietin in Tumors Enhances Virotherapy and Alleviates Cancer-related Anemia in Mice

Duong H Nguyen, Nanhai G Chen, Qian Zhang, Ha T Le, Richard J Aguilar, Yong A Yu, Joseph Cappello and Aladar A Szalay

Mol Ther 2013 21: 2054-2062; advance online publication, June 14, 2013; 10.1038/mt.2013.149

Abstract | Full Text

N-acetylcysteine Amide Augments the Therapeutic Effect of Neural Stem Cell-Based Antiglioma Oncolytic Virotherapy

Chung Kwon Kim, Atique U Ahmed, Brenda Auffinger, Ilya V Ulasov, Alex L Tobias, Kyung-Sub Moon and Maciej S Lesniak

Mol Ther 2013 21: 2063-2073; advance online publication, July 25, 2013; 10.1038/mt.2013.179

Abstract | Full Text

Vaccinia Virus Induces Programmed Necrosis in Ovarian Cancer CellsMTOPEN

Lynsey M Whilding, Kyra M Archibald, Hagen Kulbe, Frances R Balkwill, Daniel Öberg and Iain A McNeish

Mol Ther 2013 21: 2074-2086; advance online publication, September 24, 2013; 10.1038/mt.2013.195

Abstract | Full Text

Combinational Targeting Offsets Antigen Escape and Enhances Effector Functions of Adoptively Transferred T Cells in GlioblastomaMTOPEN

Meenakshi Hegde, Amanda Corder, Kevin KH Chow, Malini Mukherjee, Aidin Ashoori, Yvonne Kew, Yi Jonathan Zhang, David S Baskin, Fatima A Merchant, Vita S Brawley, Tiara T Byrd, Simone Krebs, Meng Fen Wu, Hao Liu, Helen E Heslop, Stephen Gottachalk, Eric Yvon and Nabil Ahmed

Mol Ther 2013 21: 2087-2101; advance online publication, August 13, 2013; 10.1038/mt.2013.185

Abstract | Full Text

Donor Bone Marrow–derived Dendritic Cells Prolong Corneal Allograft Survival and Promote an Intragraft Immunoregulatory Milieu

Lisa O’Flynn, Oliver Treacy, Aideen E Ryan, Maurice Morcos, Marese Cregg, Jared Gerlach, Lokesh Joshi, Mikhail Nosov and Thomas Ritter

Mol Ther 2013 21: 2102-2112; advance online publication, July 18, 2013; 10.1038/mt.2013.167

Abstract | Full Text

Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant

Ulrike Gerdemann, Usha L Katari, Anastasia Papadopoulou, Jacqueline M Keirnan, John A Craddock, Hao Liu, Caridad A Martinez, Alana Kennedy-Nasser, Kathryn S Leung, Stephen M Gottschalk, Robert A Krance, Malcolm K Brenner, Cliona M Rooney, Helen E Heslop and Ann M Leen

Mol Ther 2013 21: 2113-2121; advance online publication, June 20, 2013; 10.1038/mt.2013.151

Abstract | Full Text

Persistence and Efficacy of Second Generation CAR T Cell Against the LeY Antigen in Acute Myeloid Leukemia

David S. Ritchie, Paul J. Neeson, Amit Khot, Stefan Peinert, Tsin Tai, Kellie Tainton, Karen Chen, Mandy Shin, Dominic M. Wall, Dirk Hönemann, Peter Gambell, David A. Westerman, Javier Haurat, Jennifer A. Westwood, Andrew M. Scott, Lucy Kravets, Michael Dickinson, Joseph A. Trapani, Mark J. Smyth, Phillip K. Darcy, Michael H. Kershaw and H. Miles Prince

Mol Ther 2013 21: 2122-2129; advance online publication, July 8, 2013; 10.1038/mt.2013.154

Abstract | Full Text

Corrigendum

Top

Corrigendum: “A Comprehensive Review of Retinal Gene Therapy”

Mol Ther 2013 21: 2130; 10.1038/mt.2013.228

Full Text

Corrigendum: Reading Frame Correction by Targeted Genome Editing Restores Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients

Mol Ther 2013 21: 2130; 10.1038/mt.2013.229

Full Text

Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Molecular Therapy. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: